Contribution of adrenomedullin to the switch of G protein-coupled mu-opioid receptors from Gi to Gs in the spinal dorsal horn following chronic morphine exposure in rats
Contribution of adrenomedullin to the switch of G protein-coupled mu-opioid receptors from Gi to Gs in the spinal dorsal horn following chronic morphine exposure in rats
复制标题
大鼠慢性吗啡暴露后,肾上腺髓质素对脊髓背角 G 蛋白偶联 mu-阿片受体从 Gi 转变为 Gs 的贡献
DOI:
10.1111/bph.13419
复制
发表时间:
2016
影响因子:
7.3
通讯作者:
Hong Yanguo
中科院分区:
文献类型:
--
作者:
Wang Dongmei;Zeng Juan;Li Qi;Huang Jianzhong;Couture Rejean;Hong Yanguo
Background and PurposeChronic exposure to morphine increases spinal adrenomedullin (AM) bioactivity resulting in the development and maintenance of morphine tolerance. This study investigated the possible involvement of AM in morphine‐evoked alteration in μ‐opioid receptor‐coupled G proteins.Experimental ApproachAgents were administered intrathecally (i.t.) in rats. Nociceptive behaviours and cumulative dose–response of morphine analgesia were assessed. Neurochemicals in the spinal dorsal horn were assayed by immunoprecipitation, Western blot analysis and ELISA.Key ResultsIntrathecal injection of AM (8 μg) for 9 days decreased and increased the levels of μ receptor‐coupled Gi and Gs proteins respectively. Morphine stimulation (5 μg) after chronic treatment with AM also induced an increase in cAMP production in the spinal dorsal horn. Co‐administration of the selective AM receptor antagonist AM22–52inhibited chronic morphine‐evoked switch of G protein‐coupled μ receptor from Gi to Gs. Chronic exposure to AM increased the phosphorylation of cAMP‐responsive element‐binding protein (CREB) and ERK. Co‐administration of the PKA inhibitor H‐89 (5 μg) or MEK1 inhibitor PD98059 (1 μg) reversed the AM‐induced thermal/mechanical hypersensitivity, decline in morphine analgesic potency, switch of G protein‐coupled μ receptor and increase in cAMP.Conclusions and ImplicationsThe present study supports the hypothesis that an increase in AM activity in the spinal dorsal horn contributes to the switch of the μ receptor‐coupled G protein from Gi to Gs protein via the activation of cAMP/PKA/CREB and ERK signalling pathways in chronic morphine use.